Wird geladen...
Switch from Antagonist to Agonist after Addition of a DOTA Chelator to a Somatostatin Analog
PURPOSE: Peptide receptor targeting has become an increasingly attractive method to target tumors diagnostically and radiotherapeutically. Peptides linked to a variety of chelators have been developed for this purpose. They have, however rarely been tested for their agonistic or antagonistic propert...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2010
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3025705/ https://ncbi.nlm.nih.gov/pubmed/20396884 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-010-1445-x |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|